RxDoctor Payments Data

Sravan Panuganti, DO

Urology · Gastonia, NCNPI 1588045819

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.5%), grants and food and beverage — rather than concentrated in one kind of arrangement. Procept Biorobotics Corporation accounts for 63.2% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $61,277, more than ten times the $4,146 reported in 2019. Among urology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$176,643in general payments, 2019–2025

Across 388 payments — averaging $455.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Procept Biorobotics Corporation$112K
  • Boston Scientific$56K
  • Coloplast$3K
  • Axonics, Inc.$2K
  • Calyxo, Inc.$2K
  • Medtronic$795
  • plus $2K from 17 others
$710in research payments, 2019–2025

Across 1 payment — averaging $710.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$710

What the payments were for

  • Consulting fees$101,61058%
  • Grants$50,00028%
  • Travel & lodging$11,2276%
  • Food & beverage$13,7888%
  • Education$180%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$176,643 in reported general payments places this provider in the 95th percentile of 434 urology providers in North Carolina.

See all urology providers in North Carolina

Medicare billing

Part B allowed, 2024
$262,736
Medicare patients
652
Services billed
5,248

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron216$124,985
GemtesaVibegron46$36,467
Tamsulosin Hcl455$5,747
Estradiol80$4,570
Testosterone Cypionate63$2,451
Fesoterodine Fumarate ErFesoterodine Fumarate11$1,924
Trospium Chloride ErTrospium Chloride13$1,726
Finasteride135$1,689
Solifenacin Succinate35$1,605
Oxybutynin Chloride ErOxybutynin Chloride75$1,246
Potassium Citrate ErPotassium Citrate21$1,171
Testosterone12$1,058
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst51$894
Cephalexin253$774
Tadalafil11$715

Paid to pharmacies, not to this prescriber.

Other urology in Gastonia

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →